Latest 10-Q quarterly reports

Mangoceuticals, Inc. reported continued net losses and a significant accumulated deficit in its Q2 2026 filing, while also detailing a pending business combination with Nuclea Energy Inc. and management changes.

Cheetah Net Supply Chain Service Inc. (CTNT) reported its Q2 2026 financial results, showcasing a strategic pivot towards international trading and logistics, alongside a significant capital raise.

Greenland Energy Company, an exploration-stage oil and gas firm, filed its Q2 2026 Form 10-Q detailing significant operating expenses and net losses, alongside progress in its business combination and a recent public offering.

CIMG Inc. disclosed substantial net losses and a critical going concern warning in its latest 10-Q filing, following its delisting from the Nasdaq Capital Market.

American National Group Inc. announced a significant increase in net income for the second quarter of 2026, driven by improved investment income and favorable derivative valuations.

TMC the Metals Company Inc. filed its Q2 2026 Form 10-Q, detailing increased exploration expenses and a net loss, while advancing U.S. regulatory processes for deep-sea mining.

Tenon Medical, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing revenue growth driven by its SI joint fusion systems, but also highlighting significant operating losses and ongoing concerns about its ability to continue as a going concern.

Kochav Defense Acquisition Corp. reports its Q2 2026 financial results, highlighting interest income from its trust account while facing ongoing challenges in identifying and completing a business combination.

Pershing Square Inc. filed its Q2 2026 Form 10-Q, detailing a significant increase in assets under management and revenue growth, but also reporting a substantial net loss.

Bayview Acquisition Corp's Q2 2026 report reveals continued net losses and a significant working capital deficit, compounded by a Nasdaq delisting determination and ongoing efforts to extend its business combination deadline.

Tri Pointe Homes announced a net loss of $157.7 million for the second quarter of 2026, impacted by substantial merger-related expenses and a downturn in the housing market.

Churchill Capital Corp XI filed its Form 10-Q for the quarter ended June 30, 2026, detailing its financial status and progress towards its business combination with Agility Robotics, Inc., while acknowledging substantial going concern risks.

Oncotelic Therapeutics, Inc. filed its Q2 2026 Form 10-Q, detailing a net loss of $1.9 million for the six months ended June 30, 2026, alongside significant non-cash gains from asset revaluations and ongoing financing activities.

Stardust Power Inc. reported significant operating losses and substantial doubt about its ability to continue as a going concern in its Q2 2026 10-Q filing, exacerbated by a recent default event on its convertible note.

NET Power Inc. reported substantial impairments and ongoing legal challenges in its Q2 2026 10-Q filing, alongside a strategic pivot away from its core Oxy-Combustion Cycle technology.

Healthcare Triangle, Inc. announced its second quarter 2026 financial results, showcasing a substantial 158% year-over-year revenue increase to $9.19 million, driven by the Customer Engagement Services segment, but also reporting a widening net loss of $4.41 million.

Interlink Electronics, Inc. reported a 10.4% increase in revenue for the three months ended June 30, 2026, driven by medical and standard product sales, though a net loss persisted.

Melar Acquisition Corp. I's Q2 2026 report highlights significant cash depletion and extends its business combination deadline, while facing substantial doubt about its going concern status.

Veritone, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, revealing a continued net loss and substantial doubt about its ability to continue as a going concern, though it reported modest revenue increases in certain areas.

Trailblazer Acquisition Corp. reports its Q2 2026 financial results, highlighting interest income and continued efforts to identify a suitable business combination target within its designated sectors.

Celcuity Inc. announced FDA approval for its REVTORPYK (gedatolisib) therapy for HR+/HER2- advanced breast cancer, alongside robust clinical trial results and significant capital raises.

Muzero Acquisition Corp reports on its Q2 2026 financial status, highlighting interest income and operational expenses as it continues its search for a business combination.

Titan Acquisition Corp files its Q2 2026 Form 10-Q, detailing its ongoing search for a business combination target and financial status, with a looming liquidation deadline.

Spruce Power Holding Corporation's Q2 2026 10-Q filing reveals substantial doubt about its ability to continue as a going concern due to upcoming debt maturities and negative working capital, despite a return to net income.

AudioEye, Inc. announced its second-quarter 2026 financial results, showcasing a 9% increase in total revenue to $10.7 million and an 11% rise in ARR to $42.3 million, alongside a significant improvement in working capital.

Telomir Pharmaceuticals, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing ongoing development of Telomir-Zn, significant net losses, and substantial doubt regarding its ability to continue as a going concern.

AmperCap Acquisition Company reports on its financial condition and operational status for the quarter ended June 30, 2026, detailing its post-IPO activities and trust account management.

Aethlon Medical's Q1 2026 Form 10-Q filing details ongoing clinical development for its Hemopurifier, continued net losses, and a recent capital raise.

Intuitive Machines, Inc. reported a substantial increase in revenues for Q2 2026, largely due to the acquisition of Lanteris, but also posted a significant net loss and increased operating expenses.

Thayer Ventures Acquisition Corporation II filed its Q2 2026 Form 10-Q, detailing its financial position as a SPAC with income generated from its trust account investments.